Towards the Future of Biomedical & Pharmaceutical Research

with Organoid, Organ-on-Chip and In Silico Models

Welcome to THE 3R LÄND!

THE 3R LÄND Conference

Organoids, Organ-on-Chip, and In Silico Models have transformed biomedical and pharmaceutical research, marking a new era of experimentation. Organoids mimic the structure and function of organs, providing a physiologically human-relevant platform for disease study and drug testing. Organ-on-Chip systems replicate human organ microenvironments, offering dynamic conditions for drug assessment. In Silico Models, driven by computational simulations, expedite drug discovery by analyzing complex biological processes. These models contribute to accurate, efficient, and human-centered research, reducing reliance on animal testing and advancing biomedical and pharmaceutical sciences.

The 3R-Center Tübingen for In vitro Models and Alternatives to Animal Testing at the University of Tübingen and the NMI Natural and Medical Sciences Institute in Reutlingen is thrilled to host the first 3R LÄND Conference in the heart of the Länd, Tübingen, Germany. The conference unites academia, clinicians, industry representatives, regulatory agencies, and policymakers in the biomedical and pharmaceutical field. We invite all interested parties to join us on May 21-23, 2024, for a deep dive into the forefront of biomedical and pharmaceutical research. Engage in exciting keynote lectures, scientific presentations, poster sessions, and networking opportunities for interdisciplinary exchange.

Stay tuned for details and spread the word among your colleagues and students!

We look forward to meeting you in May 2024 in Tübingen!


The Conference will take place at the Morgenstelle Auditorium Center of the University of Tübingen.

Auditorium Center
Auf der Morgenstelle 16
72076 Tübingen

The building is barrier-free and accessible at all levels.

Important Deadlines

  • Abstract Submission: will open soon – stay tuned (Deadline January 15th, 2024)!
  • Registration: Registration will be open soon!

Updates & News

Stay up to date and find all relevant information on demand via the 3R-Centers Tübingen’s LinkedIn or the Twitter account!

Hotel Recommendations

Below you will find a list of hotels in the immediate vicinity of the venue:

Hotel & Website Address Distance to the venue
(by public transportation)
Hotel Krone Uhlandstrasse 1, 72072 Tübingen ~ 17 min
Hotel Alte Krone Kreuzstraße 21, 72074 Tübingen ~ 28 min
Hotel Ibis Style Friedrichstraße 20, 72072 Tübingen ~ 21 min
Hoppe-Seyler-Straße 6, 72076 Tübingen ~ 10 min
Hotel Metora Weizsäckerstraße 1, 72074 Tübingen ~ 24 min
Hotel Barbarina Wilhelmstraße 94, 72074 Tübingen ~ 21 min
Hotel Domizil Wöhrdstrasse 5-9, 72072 Tübingen ~ 19 min
Hotel Katharina Garni Lessingweg 2 , 72076 Tübingen ~ 18 min
Hotel Restaurant „Kreuzberg” Vor dem Kreuzberg 23, 72070 Tübingen ~ 24 min
Hotel am Schloss Burgsteige 18, 72070 Tübingen ~ 24 min
Hotel Venezia Dieselstraße 2, 72074 Tübingen-Lustnau ~ 26 min
Hermann-Kurz-Str. 4, 72074 Tuebingen ~ 25 min


  • Keynote Lectures and Expert Presentations
  • Oral Presentations meticulously selected from the submitted abstracts
  • Poster Presentations
  • Rapid-Fire Pitch Talks

Session Topics

  • Innovation in Organ-on-Chip Models
  • Innovation in Organoid Models
  • Innovation in In Silico Models
  • Application of NAMs for Personalized Medicine
  • Training and Education for NAMs
  • Use of NAMs in Industrial Research
  • NAM-based Basic Biomedical Research
  • Ethical Considerations around Microphysiological Systems

Keynote Speaker

Prof. Dr. Josef Penninger

Josef Penninger born in Gurten, Austria, is since July 1, 2023 the Scientific Director of the Helmholtz Centre for Infection Research in Germany. At the same time, he was appointed part-time Professor for Precision Medicine at the Medical University of Vienna. Josef Penninger studied medicine at the University of Innsbruck. From 1990 to 1994 he worked as post-doctoral fellow at the Ontario Cancer Institute, thereafter until 2002 at the Department of Immunology and Medical Biophysics at the University of Toronto. As Principal Investigator at Amgen, his independent lab contributed to the development of the antibody Denosumab for bone loss and found the first connection for RANKL to mammary gland development in pregnancy and breast cancer. In 2002, he moved to Vienna, to start and develop the Institute of Molecular Biotechnology of the Austrian Academy of Sciences, which has become one of the prime research centers in the world. From the end of 2018 to June 2023 Josef Penninger returned to Canada and was the Director of the Life Sciences Institute at the University of British Columbia. Dr. Penninger created a similar environment at the LSI that nurtured and trained the best and brightest young minds of UBC scholars. His major accomplishments include pioneering insights into the molecular basis of osteoporosis and breast cancer and demonstrating a critical role for ACE2 as the cellular receptor for SARS Coronavirus infections and linking ACE2 to lung failure in such infections.

Prof. Dr. Peter Loskill

Prof. Dr. Peter Loskill is Full Professor for Organ-on-Chip (OoC) Research at the Eberhard Karls University Tübingen (EKUT) and the NMI Natural and Medical Sciences Institute at the University of Tübingen in Reutlingen, and head of the 3R-Center Tübingen for In vitro Models and Alternatives to Animal Testing. Dr. Loskill graduated in 2012 from Saarland University with a PhD in Physics focusing on Biointerface Science. He then spent three years as postdoctoral fellow in the Healy lab at University of California at Berkeley developing human induced pluripotent stem cells (hiPSC)-based OoC models, funded by the NIH/NCATS TissueChip program and the German Science Foundation (DFG). In 2015, he was named as one of Technology Review’s “Innovators under 35 Germany” and awarded a Fraunhofer ATTRACT Grant, the highest funded German starting grant program, which enabled him to start an independent research group at Fraunhofer IGB Stuttgart. In 2021, he accepted a W3-professor position, heading the Department for Microphysiological Systems in the Faculty of Medicine at EKUT and NMI. From 2021 to 2023, he served as the Chair of the European Organ-on-Chip Society (EUROoCS) and, in 2023, he became part of the governing board of the International MPS Society (iMPSS). Dr. Loskill and his interdisciplinary µOrganoLab merge engineering, biology, physics, and medicine to generate next generation tissue models recapitulating complex human biology in vitro. His research focuses on i) development of tailored OoC platforms, ii) application of OoCs for pharmaceutical research, toxicological screening, and biomedical studies, as well as on iii) enabling technologies that support parallelization, automation, and ease of use.

More Keynote Speaker will be announced soon!

Abstract Submission

Technical Requirements & Deadline

  • File Submission Guidelines:
    • Template: Please utilize the provided template for abstract preparation. Download the template, fill in your details, and save the document in PDF format. Upload the completed PDF using the form below.
    • Language and Word Limit: Abstracts must be in English and should not exceed 350 words (including references; excluding title and authors).
    • File Format and Size: Please upload a single PDF file with a file size not exceeding 5 MB. Incomplete applications cannot be considered.
    • Abstract Evaluation and Selection: All abstracts will be evaluated and selected for oral or poster presentation by the Program Committee
    • Author Information: Full first and last names of all authors; abbreviate middle names (e.g., Peter R. S. Parker); presenting author should be identified. Provide affiliations including institute/company, town, and country for each author. E-mail address of presenting author should be provided.
    • Additional Information in Abstract: Acknowledgements, disclaimers or funding information may be included at the end of the abstract.
  • Confidentiality Note:
    • Kindly refrain from including any confidential material in your abstracts. Note that all accepted abstracts will be freely accessible to all conference participants.
  • Presentation Selection:
    • Submitted abstracts will be considered for either oral presentation or inclusion in the interactive poster session.
  • Author Limitation:
    • Each presenting author is allowed to submit only one abstract.
  • Conference Registration Requirement:
    • It is mandatory for all presenters to be registered for the conference if their abstract is accepted.

Deadline for Abstract Submission

  • The deadline for submitting abstracts is Monday, January, 15th, 2024

Notice to Authors

  • Authors will be notified on the decision of the Program Committee by February, 14th, 2024

Submit your Abstract

    (Young investigators: undergraduate and graduate students, PhD candidates)

    Oral presentationPoster presentation

    Please use the provided template, and upload only one file in PDF format which is below 5 MB of file size. We cannot consider applications which are not complete.

    I have read the data protection regulations and agree to the data processing

    We will treat your personal data confidentially and in accordance with the statutory data protection regulations and the privacy policy. Your data will of course be treated confidentially. By checking the box, you declare that you are familiar with and agree to the privacy policy listed at: Data privacy


    Registration for THE 3R-LÄND Conference 2024 will open soon.


    Registration Fee & Deadlines

    • Early Bird (until March 1st, 2024)
      • € 200
    • Regular (from March 2nd, 2024 onwards)
      • € 250

    Stay in Touch!

    Stay up to date! Check out Social Media (LinkedIn & Twitter/X) channels to not miss any news on the Annual 3R-Conference!


    Annual Conference of the 3R-Network Baden-Württemberg

    You have questions on the „THE 3R LÄND Conference“?